Evidence map›Paper›PMID 39050532›Full record

ArticleFrontiers in medicine2024

Clinical efficacy of CO

Lina Zhang, Jianzhong Zhang, Xin Wang, Zhonglin Zhao, Zhifeng Li, Guoying Miao, Chao Lv

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lina Zhang *Dermatology Department, Affiliated Hospital of Hebei Engineering University, Handan, China.
Jianzhong Zhang *Dermatology Department, Affiliated Hospital of Hebei Engineering University, Handan, China.
Xin WangDermatology Department, Affiliated Hospital of Hebei Engineering University, Handan, China.
Zhonglin ZhaoDermatology Department, Affiliated Hospital of Hebei Engineering University, Handan, China.
Zhifeng LiDermatology Department, Affiliated Hospital of Hebei Engineering University, Handan, China.
Guoying MiaoDermatology Department, Affiliated Hospital of Hebei Engineering University, Handan, China.
Chao LvDermatology Department, Affiliated Hospital of Hebei Engineering University, Handan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To analyze the clinical efficacy of CO Methods: The clinical treatment effects, levels of inflammatory factors [interleukin-17 (IL-17), interferon-gamma (IFN-γ), interleukin-10 (IL-10)], prognosis regarding repigmentation and relapse, psychological health (satisfaction). Results: ① Clinical treatment effects: the total effective rate in Group A was 92.73%, Group B was 74.55%, and Group C was 67.27%, with Group A showing significantly higher effectiveness than Groups B and C ( Conclusion: The application of CO

Indexed as

clinical efficacyCO2 fractional lasercompound betamethasoneimpactinflammatory factorsvitiligo

Identifiers

PMID39050532
PMCPMC11266084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.